These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2099404)

  • 21. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase.
    Bell PB; Rooney N; Bosanquet AG
    Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic immunoglobulins in B cell chronic lymphocytic leukemia (B-CLL).
    Coser P; Pianezze G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():151-2. PubMed ID: 2653493
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL.
    Dighiero G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):283-8. PubMed ID: 3065729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
    Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant CD5 B cells--biased immunoglobulin variable gene usage and autoantibody production.
    Mayer R; Stone K; Han A; Bona C
    Int Rev Immunol; 1991; 7(3):189-203. PubMed ID: 1721931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoimmune diseases and malignant lymphoma].
    Müller-Hermelink HK; Greiner A
    Verh Dtsch Ges Pathol; 1992; 76():96-109. PubMed ID: 1283281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies.
    Borche L; Lim A; Binet JL; Dighiero G
    Blood; 1990 Aug; 76(3):562-9. PubMed ID: 2378986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas.
    Dighiero G; Hart S; Lim A; Borche L; Levy R; Miller RA
    Blood; 1991 Aug; 78(3):581-5. PubMed ID: 1859876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoreactive B-cell repertoire.
    Dighiero G
    Immunol Ser; 1991; 55():39-60. PubMed ID: 1954291
    [No Abstract]   [Full Text] [Related]  

  • 33. CD5 B cells, a fetal B cell lineage.
    Hardy RR; Hayakawa K
    Adv Immunol; 1994; 55():297-339. PubMed ID: 7508175
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic lymphocytic leukemia: "Cinderella" is becoming a star.
    Caligaris-Cappio F
    Mol Med; 2009; 15(3-4):67-9. PubMed ID: 19081769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoreactive T-cell-dependent polyclonal B-cell differentiation in mantle zone lymphoma.
    Hirokawa M; Lee M; Chubachi A; Kitabayashi A; Itoh T; Miura I; Miura AB
    Blood; 1993 May; 81(10):2816. PubMed ID: 8490188
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial HLDA9 special issue.
    Engel P
    Immunol Lett; 2011 Jan; 134(2):103. PubMed ID: 21093483
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmunity checkpoints as therapeutic targets in B cell malignancies.
    Müschen M
    Nat Rev Cancer; 2018 Feb; 18(2):103-116. PubMed ID: 29302068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity. Deletion of autoreactive B cells.
    MacLennan IC
    Curr Biol; 1995 Feb; 5(2):103-6. PubMed ID: 7743168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Community series in mouse models of B cell malignancies, volume II.
    Perez-Chacon G; Vincent-Fabert C; Zapata JM
    Front Immunol; 2024; 15():1488601. PubMed ID: 39376568
    [No Abstract]   [Full Text] [Related]  

  • 40. Can isoelectric focusing reduce the number of samples requiring immunofixation?
    Liu D; Read A; Hjelm NM
    Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():769-70. PubMed ID: 10586316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.